What's in iRegene Therapeutics Co., Ltd.'s pipeline?

iRegene Therapeutics Co., Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with iRegene Therapeutics Co., Ltd.'s portfolio?

Top competitors by shared drug class: Biosolution Co., Ltd., Bone Therapeutics S.A, Brainstorm-Cell Therapeutics, Celavie Bioscences, LLC, China Spinal Cord Injury Network.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/iregene-therapeutics-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

iRegene Therapeutics Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iRegene Therapeutics Co., Ltd. pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biosolution Co., Ltd. · 1 shared drug class
Bone Therapeutics S.A · 1 shared drug class
Brainstorm-Cell Therapeutics · 1 shared drug class
Celavie Bioscences, LLC · 1 shared drug class
China Spinal Cord Injury Network · 1 shared drug class
City of Hope Medical Center · 1 shared drug class
DiscGenics, Inc. · 1 shared drug class
Avicenna Research Institute · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for iRegene Therapeutics Co., Ltd.:

Cite this brief

Drug Landscape (2026). iRegene Therapeutics Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/iregene-therapeutics-co-ltd. Accessed 2026-05-16.